Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen Spray
- Manufacturer
- Baxter Laboratories Pty. Ltd.
- Effective date
- 2024-01-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:12:22
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%
OTC - PURPOSE SECTION
Purpose: Sunscreen
INDICATIONS & USAGE SECTION
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures ( see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
WARNINGS SECTION
Warnings
For external use only
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
OTC - WHEN USING SECTION
When using this product
keep out of eyes. Rinse with water to remove.
DOSAGE & ADMINISTRATION SECTION
Directions
- Apply liberally 15 minutes before sun exposure.
- Reapply:
- after 80 minutes of swimming or sweating
- immediately after towel drying
- at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m.- 2 p.m.
- Wear long-sleeved shirts, pants, hats, and sunglasses.
- Children under 6 months: Ask a doctor.
OTHER SAFETY INFORMATION
- Protect the product in this container from excessive heat and direct sun.
- You may report a serious adverse reaction to 888-266-0772; Monday – Friday, 9 am – 5 pm.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Water, Beeswax, C12-15 Alkyl Benzoate, Silica, PEG-15 Cocamine, Caprylyl Glycol, PEG-40 Stearate, Acrylates/Steareth-20 Methacrylate Copolymer, Caprylhydroxamic Acid, Glycerin, Carbomer, Sodium Hydroxide, Phenoxyethanol, Sodium Carrageenan, Aloe Barbadensis Leaf Juice, Tocopheryl Acetate, Sodium Chloride.
OTC - QUESTIONS SECTION
Questions?
888-266-0772 or visit bondisands.com
Product Packaging
bondi sands
The Australian tan
BROAD SPECTRUM
HYDRA
UV PROTECT
SPF 70
SUNSCREEN SPRAY
VERY WATER RESISTANT 80 MINUTES
PLANT BASED HYDRATION
REEF FRIENDLY
Australian Made
5.07 FL. OZ. (150mL)
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70157-017 | BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) SPRAY [BAXTER LABORATORIES PTY. LTD.] | 1 | Unmatched | 20240127_0fcd3aad-a828-7f12-e063-6394a90a2d54.zip |
Products#
Every source-derived product name is available through these pages.
- Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen
- Avobenzone, Homosalate, Octisalate, Octocrylene
- CAPRYLHYDROXAMIC ACID
- PHENOXYETHANOL
- ALKYL (C12-15) BENZOATE
- SILICON DIOXIDE
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
- WATER
- ALOE VERA LEAF
- .ALPHA.-TOCOPHEROL ACETATE
- PEG-15 COCAMINE
- CARRAGEENAN
- YELLOW WAX
- SODIUM HYDROXIDE
- GLYCERIN
- SODIUM CHLORIDE
- PEG-40 STEARATE
- CAPRYLYL GLYCOL
- ETHYL ACRYLATE/METHACRYLIC ACID/STEARETH-20 METHACRYLATE COPOLYMER
- AVOBENZONE
- OCTOCRYLENE
- HOMOSALATE
- OCTISALATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70157-017 | 70157-017-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4c75592b-1c26-7aeb-e063-6394a90a1c14 | 0fcd3aad-a828-7f12-e063-6394a90a2d54 | 2026-03-07 | Warnings | 0fcd3aad-a828-7f12-e063-6394a90a2d54 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
